|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 233/88 | (2006.01) |
| C07D 417/14 | (2006.01) | ||
| A61K 31/4164 | (2006.01) | ||
| A61P 25/28 | (2006.01) |
| (11) | Number of the document | 1730119 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05708746.2 |
| Date of filing the European patent application | 2005-03-11 | |
| (97) | Date of publication of the European application | 2006-12-13 |
| (45) | Date of publication and mention of the grant of the patent | 2008-06-25 |
| (46) | Date of publication of the claims translation | 2008-11-25 |
| (86) | Number | PCT/IB2005/000659 |
| Date | 2005-03-11 |
| (87) | Number | WO 2005/092864 |
| Date | 2005-10-06 |
| (30) | Number | Date | Country code |
| 555623 P | 2004-03-23 | US |
| (72) |
BRODNEY, Michael, Aaron, Pfizer Global Res. & Dev., US
COFFMAN, Karen, Jean, Pfizer Global Res. & Dev., US
|
| (73) |
Pfizer Products Inc.,
Eastern Point Road, Groton, CT 06340,
US
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Imidazolo junginiai, skirti neurodegeneracinių ligų gydymui |
| IMIDAZOLE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS |
| Payment date | Validity (years) | Amount | |
| 2016-02-26 | 12 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2017-03-11 |